Cargando…

Fragmentation of Human Neutrophil α-Defensin 4 to Combat Multidrug Resistant Bacteria

The occurrence and spread of multidrug-resistant bacteria is a prominent health concern. To curb this urgent threat, new innovative strategies pursuing novel antimicrobial agents are of the utmost importance. Here, we unleashed the antimicrobial activity of human neutrophil peptide-4 (HNP-4) by tryp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ehmann, Dirk, Koeninger, Louis, Wendler, Judith, Malek, Nisar P., Stange, Eduard F., Wehkamp, Jan, Jensen, Benjamin A. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286198/ https://www.ncbi.nlm.nih.gov/pubmed/32582092 http://dx.doi.org/10.3389/fmicb.2020.01147

Ejemplares similares

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments
por: Ehmann, D., et al.
Publicado: (2019)

Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide
por: Wendler, Judith, et al.
Publicado: (2019)

Curbing gastrointestinal infections by defensin fragment modifications without harming commensal microbiota
por: Koeninger, Louis, et al.
Publicado: (2021)

Human β-Defensin 2 Mediated Immune Modulation as Treatment for Experimental Colitis
por: Koeninger, Louis, et al.
Publicado: (2020)

Innate immunity includes defensins
por: Jäger, Simon, et al.
Publicado: (2012)

Human α-Defensin 5(1–9) and Human β-Defensin 2 Improve Metabolic Parameters and Gut Barrier Function in Mice Fed a Western-Style Diet
por: Filipe Rosa, Louisa, et al.
Publicado: (2023)

Paneth cell α-defensin 6 (HD-6) is an antimicrobial peptide
por: Schroeder, B O, et al.
Publicado: (2015)

β-Defensin 1 Is Prominent in the Liver and Induced During Cholestasis by Bilirubin and Bile Acids via Farnesoid X Receptor and Constitutive Androstane Receptor
por: Klag, Thomas, et al.
Publicado: (2018)

Ubiquitously expressed Human Beta Defensin 1 (hBD1) forms bacteria-entrapping nets in a redox dependent mode of action
por: Raschig, Judith, et al.
Publicado: (2017)

Histone deacetylase-mediated regulation of the antimicrobial peptide hBD2 differs in intestinal cell lines and cultured tissue
por: Stebe-Frick, Sabrina, et al.
Publicado: (2018)

Ustekinumab is effective in biological refractory Crohn’s disease patients–regardless of approval study selection criteria
por: Saman, Sadik, et al.
Publicado: (2019)

Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin
por: Jaeger, S U, et al.
Publicado: (2013)

Prospects for the Use of New Technologies to Combat Multidrug-Resistant Bacteria
por: Lima, Renata, et al.
Publicado: (2019)

Boosting nanotoxicity to combat multidrug-resistant bacteria in pathophysiological environments
por: Westmeier, Dana, et al.
Publicado: (2020)

Probiotic E. coli treatment mediates antimicrobial human β-defensin synthesis and fecal excretion in humans
por: Möndel, M, et al.
Publicado: (2009)

GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting
por: Schoeler, Marc, et al.
Publicado: (2018)

Silver-Containing Titanium Dioxide Nanocapsules for Combating Multidrug-Resistant Bacteria
por: Hérault, Nelly, et al.
Publicado: (2020)

Recent advances in understanding and managing Crohn’s disease
por: Stange, Eduard F., et al.
Publicado: (2016)

Recent advances and emerging therapies in the non-surgical management of ulcerative colitis
por: Wehkamp, Jan, et al.
Publicado: (2018)

An Update Review on the Paneth Cell as Key to Ileal Crohn's Disease
por: Wehkamp, Jan, et al.
Publicado: (2020)

Influence of NOD2 Variants on Trichuris suis ova Treatment Outcome in Crohn’s Disease
por: Jaeger, Simon U., et al.
Publicado: (2018)

Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo
por: Becker, Svetlana, et al.
Publicado: (2013)

Engineered Cationic Antimicrobial Peptides (eCAPs) to Combat Multidrug-Resistant Bacteria
por: Deslouches, Berthony, et al.
Publicado: (2020)

Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria
por: Kirienko, Natalia V., et al.
Publicado: (2019)

Urgent need for novel antibiotics in Republic of Korea to combat multidrug-resistant bacteria
por: Lee, Hyo-Jin, et al.
Publicado: (2022)

Combining flagellin and human β-defensin-3 to combat bacterial infections
por: Sabag, Ofra, et al.
Publicado: (2014)

Promising role of defensins peptides as therapeutics to combat against viral infection
por: Solanki, Subhash Singh, et al.
Publicado: (2021)

Processing of Neutrophil α-Defensins Does Not Rely on Serine Proteases In Vivo
por: Glenthøj, Andreas, et al.
Publicado: (2015)

Antimicrobial Peptides in Gastrointestinal Inflammation
por: Jäger, Simon, et al.
Publicado: (2010)

In the Wnt of Paneth Cells: Immune-Epithelial Crosstalk in Small Intestinal Crohn’s Disease
por: Armbruster, Nicole S., et al.
Publicado: (2017)

Correction: Bacteria Regulate Intestinal Epithelial Cell Differentiation Factors Both In Vitro and In Vivo
por: Becker, Svetlana, et al.
Publicado: (2013)

Human Neutrophil α-Defensins 1–3 Are Upregulated in the Microenvironment of Fibrotic Liver
por: Abu Fanne, Rami, et al.
Publicado: (2023)

Antimicrobial peptides and gut microbiota in homeostasis and pathology
por: Ostaff, Maureen J, et al.
Publicado: (2013)

Medical Therapy of Perianal Crohn's Disease
por: Klag, Thomas, et al.
Publicado: (2015)

Designing double-site lipidated peptide amphiphiles as potent antimicrobial biomaterials to combat multidrug-resistant bacteria
por: Lai, Zhenheng, et al.
Publicado: (2022)

Nanotechnology as a Promising Approach to Combat Multidrug Resistant Bacteria: A Comprehensive Review and Future Perspectives
por: Hetta, Helal F., et al.
Publicado: (2023)

A photoactivatable and phenylboronic acid-functionalized nanoassembly for combating multidrug-resistant gram-negative bacteria and their biofilms
por: Zhou, Xiaoqing, et al.
Publicado: (2023)

Differential Susceptibility of Bacteria to Mouse Paneth Cell α-Defensins under Anaerobic Conditions
por: Mastroianni, Jennifer R., et al.
Publicado: (2014)

Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’
por: Khan, Shahper N., et al.
Publicado: (2016)

Combating multidrug‐resistant Plasmodium falciparum malaria
por: Thu, Aung Myint, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g4ojk90m2kc1ph0miet734pn3k